tryptophan hydroxylase 1 ; Rattus norvegicus






167 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 850134 Modulation of brain tryptophan hydroxylase activity by brain tryptophan content. J Pharmacol Exp Ther 1977 Apr 5
2 1349640 Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphetamine, two metabolites of 3,4-methylenedioxymethamphetamine, on central serotonergic and dopaminergic systems. J Pharmacol Exp Ther 1992 May 3
3 1358654 Long-term alteration in the central monoaminergic systems of the rat by 2,4,5-trihydroxyamphetamine but not by 2-hydroxy-4,5-methylenedioxymethamphetamine or 2-hydroxy-4,5-methylenedioxyamphetamine. Eur J Pharmacol 1992 Oct 20 5
4 1374469 Effect of flunarizine and nimodipine on the decrease in tryptophan hydroxylase activity induced by methamphetamine and 3,4-methylenedioxymethamphetamine. J Pharmacol Exp Ther 1992 May 14
5 1475314 Activity of tryptophan hydroxylase in brain of hereditary predisposed to catalepsy rats. Pharmacol Biochem Behav 1992 Dec 3
6 1698245 Tryptophan hydroxylase inhibition increases preprotachykinin mRNA in developing and adult medullary raphe nuclei. Brain Res Mol Brain Res 1990 Jul 5
7 1717871 Norepinephrine does not contribute to methamphetamine-induced changes in hippocampal serotonergic system. Neuropharmacology 1991 Jun 5
8 1974853 Reversal of the acute effects of 3,4-methylenedioxymethamphetamine by 5-HT uptake inhibitors. Eur J Pharmacol 1990 May 31 3
9 2176712 Increased tryptophan hydroxylase mRNA in raphe serotonergic neurons spared by 5,7-dihydroxytryptamine. Brain Res Mol Brain Res 1990 Oct 1
10 2414113 The acute effects of methamphetamine, amphetamine and p-chloroamphetamine on the cortical serotonergic system of the rat brain: evidence for differences in the effects of methamphetamine and amphetamine. Eur J Pharmacol 1985 Oct 8 2
11 2421731 Increased tryptophan hydroxylase activity in serotonergic nerve terminals spared by 5,7-dihydroxytryptamine. Biochem Pharmacol 1986 Apr 15 1
12 2436623 Cerebral serotonin regulation by phenylalanine analogues and during hyperphenylalaninemia. Biochem Pharmacol 1987 Mar 15 5
13 2446629 Effects of N-ethyl-3,4-methylenedioxyamphetamine (MDE) on central serotonergic and dopaminergic systems of the rat. Biochem Pharmacol 1987 Dec 1 2
14 2449619 The effects of amphetamine-like designer drugs on monoaminergic systems in rat brain. NIDA Res Monogr 1987 3
15 2463176 Direct central effects of acute methylenedioxymethamphetamine on serotonergic neurons. Eur J Pharmacol 1988 Oct 26 2
16 2523524 Tryptophan hydroxylase activity and 5-hydroxytryptamine-immunoreactive cells in the superior cervical ganglion of hydrocortisone-treated neonatal rats. Neurosci Res 1989 Feb 3
17 2530476 Tryptophan hydroxylase activity in hypothalamus and brainstem of neonatal and adult rats treated with hydrocortisone or parachlorophenylalanine. Neurosci Res 1989 Oct 12
18 2570704 Effect of MK-801 on the decrease in tryptophan hydroxylase induced by methamphetamine and its methylenedioxy analog. Eur J Pharmacol 1989 Jun 20 15
19 2871513 Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal tyrosine hydroxylase and tryptophan hydroxylase in rat. Neuropharmacology 1986 Mar 4
20 2875893 The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain. Eur J Pharmacol 1986 Aug 22 2
21 2884120 Role of the dopaminergic nigrostriatal pathway in methamphetamine-induced depression of the neostriatal serotonergic system. Eur J Pharmacol 1987 Mar 17 10
22 2902215 Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine. J Pharmacol Exp Ther 1988 Oct 10
23 3119509 Impact of amino acid imbalance on brain amines. Int J Vitam Nutr Res 1987 2
24 3742199 Postnatal developmental changes of tryptophan hydroxylase activity in serotonergic cell bodies and terminals of rat brain. Brain Res 1986 Jul 16 2
25 6104722 Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J Pharmacol Exp Ther 1980 Aug 9
26 6120843 Methamphetamine-induced depression of tryptophan hydroxylase: recovery following acute treatment. Eur J Pharmacol 1981 Dec 3 4
27 6121011 Biochemical evidence for alteration of neostriatal dopaminergic function by 5,7-dihydroxytryptamine. J Neurochem 1982 May 6
28 6187915 Effects of a single dose of methamphetamine and iprindole on the serotonergic and dopaminergic system of the rat brain. J Pharmacol Exp Ther 1983 Apr 1
29 7274094 Maternal influences on tryptophan hydroxylase activity in embryonic rat brain. Dev Neurosci 1981 4
30 7460794 Glucocorticoids as a regulatory factor for brain tryptophan hydroxylase during development. Dev Neurosci 1980 3
31 7499362 Identification of the site of interaction of the 14-3-3 protein with phosphorylated tryptophan hydroxylase. J Biol Chem 1995 Dec 1 2
32 7538579 The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits. J Pharmacol Exp Ther 1995 May 3
33 7812764 Structural studies of condensation products of biogenic amines as inhibitors of tryptophan hydroxylase. Brain Res 1994 Aug 29 16
34 7902421 Chronic cocaine administration increases CNS tyrosine hydroxylase enzyme activity and mRNA levels and tryptophan hydroxylase enzyme activity levels. J Neurochem 1993 Dec 7
35 7965075 Distinct regulatory pathways control neurofilament expression and neurotransmitter synthesis in immortalized serotonergic neurons. J Neurosci 1994 Nov 2
36 8015380 Early induction of rat brain tryptophan hydroxylase (TPH) mRNA following parachlorophenylalanine (PCPA) treatment. Brain Res Mol Brain Res 1994 Mar 10
37 8254360 Increase of tryptophan hydroxylase enzyme protein by dexamethasone in adrenalectomized rat midbrain. J Neurosci 1993 Dec 1
38 8369965 Acute effects of reserpine on tryptophan hydroxylase activity and mRNA in rat brain. Brain Res 1993 Aug 27 1
39 8412572 Effect of d-fenfluramine and 5,7-dihydroxytryptamine on the levels of tryptophan hydroxylase and its mRNA in rat brain. Brain Res Mol Brain Res 1993 Aug 5
40 8496826 Short-term effects of 2,4,5-trihydroxyamphetamine, 2,4,5-trihydroxymethamphetamine and 3,4-dihydroxymethamphetamine on central tryptophan hydroxylase activity. J Pharmacol Exp Ther 1993 May 14
41 8508321 Changes in activity and mRNA for rat tryptophan hydroxylase and aromatic L-amino acid decarboxylase of brain serotonergic cell bodies and terminals following neonatal 5,7-dihydroxytryptamine. Brain Res 1993 Apr 23 5
42 8592107 Adrenocorticotropic hormone activation of adenylate cyclase in raphe neurons: multiple regulatory pathways control serotonergic neuronal differentiation. J Neurobiol 1995 Dec 1
43 8743605 Effects of antimuscarinic antiparkinsonian drugs on brightness discrimination performance in rats. Pharmacol Biochem Behav 1996 Jun 2
44 8828572 Ipsilateral alterations in tryptophan hydroxylase activity in rat brain after hypothalamic 5,7-di-hydroxytryptamine lesion. Brain Res 1996 Jun 17 9
45 8883942 Effects of dexfenfluramine or 5,7-dihydroxytryptamine on tryptophan hydroxylase and serotonin transporter mRNAS in rat dorsal raphe. Brain Res Mol Brain Res 1996 Sep 5 3
46 8888941 Modulation of tryptophan hydroxylase activity in vitro by ethanol depends on biopterin cofactor concentration. Alcohol 1996 Sep-Oct 11
47 8989773 Thyroid parafollicular cells. An accessible model for the study of serotonergic neurons. Mol Neurobiol 1996 Dec 1
48 9332732 Tissue-specific glucocorticoid regulation of tryptophan hydroxylase mRNA levels. Brain Res Mol Brain Res 1997 Sep 10
49 9336334 Interaction between hyperthermia and oxygen radical formation in the 5-hydroxytryptaminergic response to a single methamphetamine administration. J Pharmacol Exp Ther 1997 Oct 11
50 9450514 Localization of GTP cyclohydrolase in monoaminergic but not nitric oxide-producing cells. Synapse 1998 Feb 2